Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

5-Alpha-Reductase Inhibitors can cause negative side effects.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

The cream effectively reduced hair growth on forearms.

Serotonin helps wounds heal faster.

New treatments for male hair loss are being explored to improve effectiveness and reduce side effects.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

5 alpha-reductase inhibitors, like finasteride, are used to treat conditions like prostate issues and skin disorders.

Finasteride can cause melasma, especially in people with darker skin.

Taking medication for hair loss might cause sexual problems.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Combining fractional CO2 laser or microneedling with 5-FU is more effective and safer for treating vitiligo.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

The higher dose supplement was more effective in treating female hair loss.

The "Opus-5" diode laser is effective for treating oral submucous fibrosis.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

CO2 fractional laser treatment helped regrow hair in a 13-year-old with alopecia areata.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.